ACP
COCH icon

Arcus Capital Partners’s Envoy Medical COCH Stock Holding History

Arcus Capital Partners’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Hold
187,573
– – 0.06% 108
2026
Q1 		$125K Hold
187,573
– – 0.04% 118
2025
Q4 		$124K Buy
187,573
+34,705
+23% +$27.5K 0.04% 140
2025
Q3 		$119K Sell
152,868
-34,705
-19% -$47.1K 0.05% 112
2025
Q2 		$266K Hold
187,573
– – 0.12% 102
2025
Q1 		$244K Buy
+187,573
New +$275K 0.1% 103

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Arcus Capital Partners's COCH Position: Q2 2026 in Review

Arcus Capital Partners held its Envoy Medical (COCH) position steady in Q2 2026 at 187,573 shares worth $149K. The position accounts for 0.06% of the portfolio, ranked #108.

Arcus Capital Partners first reported a position in COCH in Q1 2025 and has held it in 6 quarters since. The position peaked at $266K in Q2 2025. 31 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Arcus Capital Partners held 187,573 shares of Envoy Medical worth $149K as of Q2 2026.
  • Arcus Capital Partners left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up 0.06% of Arcus Capital Partners's portfolio in Q2 2026, its #108 holding.
  • Arcus Capital Partners first reported a position in Envoy Medical in Q1 2025 and has held it in 6 quarters since.
  • Arcus Capital Partners's Envoy Medical position peaked at $266K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Arcus Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.